Financials in USD. Standardized financial statements.
A compact view of how Jack Nathan Medical Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $8.71M | $19.14M | $15.49M | $9.64M | $3.85M | $3.62M | $2.93M |
| Revenue Growth? | -54.5% | +23.6% | +60.7% | +150.2% | +6.5% | +23.7% | 0.0% |
| Cost of Revenue? | $1.34M | $4.67M | $3.67M | $2.71M | $74,433 | $841,224 | $800,533 |
| Gross Profit? | $7.37M | $14.48M | $11.82M | $6.92M | $3.78M | $2.78M | $2.12M |
| Gross Margin? | +84.7% | +75.6% | +76.3% | +71.8% | +98.1% | +76.7% | +72.6% |
| Operating Expenses? | $9.85M | $20.92M | $17.12M | $14.43M | $4.41M | $134,615 | $18,085 |
| Operating Income? | -$2.48M | -$2.30M | -$6.96M | -$8.47M | -$1.35M | -$134,615 | -$18,085 |
| EBITDA? | -$1.54M | -$4.31M | -$4.41M | -$6.10M | -$10.11M | $196,262 | -$18,085 |
| Income Before Tax | -$2.51M | -$2.14M | -$6.99M | -$8.23M | -$10.29M | -$134,615 | -$18,085 |
| Income Tax Expense | $16,346 | $805,843 | -$85,966 | -$217,543 | -$380,919 | $23,404 | -$171,860 |
| Net Income? | $7.46M | -$6.64M | -$7.08M | -$7.81M | -$9.91M | -$134,615 | -$18,085 |
| EPS? | $-0.03 | $-0.08 | $-0.08 | $-0.09 | $-0.19 | $-0.13 | $-0.01 |
| Diluted EPS? | $-0.03 | $-0.08 | $-0.08 | $-0.09 | $-0.19 | $-0.13 | $-0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality